<PAGE> 1
EXHIBIT 99.1
[RENAL CARE GROUP lOGO]
----------
NEWS RELEASE
FOR IMMEDIATE RELEASE CONTACT: R. DIRK ALLISON
CHIEF FINANCIAL OFFICER
615-345-5500
RENAL CARE GROUP'S BOARD AUTHORIZES
$50 MILLION STOCK REPURCHASE
Nashville, Tennessee (October 2, 2000)--Renal Care Group, Inc. (Nasdaq/NM: RCGI)
today announced that its Board of Directors has authorized the Company to expend
up to $50 million to repurchase the Company's common stock. The purchases are to
be made from time to time over the next 12 months on the Nasdaq Stock Market's
National Market at prices prevailing on that market or in privately negotiated
transactions on conditions acceptable to the Company. Renal Care Group currently
has approximately 48 million shares of common stock outstanding. Based on
Friday's closing price, Renal Care Group could buy back approximately 2.7
million shares. The Company expects to fund its purchases from working capital
and credit available under its bank credit agreement.
Sam A. Brooks, chairman and chief executive officer of Renal Care
Group, said, "We are pleased that the Board has chosen to support a share
repurchase program which affirms Renal Care Group's positive outlook. It is our
belief that the Company's shares at current market prices represent an
attractive investment for the Company.
Renal Care Group, Inc. is a dialysis services company that provides
care to patients with kidney disease. The Company treats approximately 15,900
patients through 193 dialysis centers, in addition to providing acute dialysis
services in 108 hospitals. Over 5,000 associates provide services in the
Company's 23-state network.
Certain statements in this press release constitute "forward-looking
statements" within the meaning of the Private Securities Litigation Reform Act
of 1995. These forward-looking statements reflect management's expectations and
are based upon currently available information. These forward-looking statements
involve known and unknown risks, uncertainties and other factors that may cause
actual results, performance or achievements of Renal Care Group to differ
materially from those expressed in or implied by the forward-looking statements.
These factors are discussed in more detail in the Company's reports filed with
the Securities and Exchange Commission, including without limitation Renal Care
Group's annual report on Form 10-K for the year ended December 31, 1999 and
Renal Care Group's quarterly reports on From 10-Q for the quarters ended March
31, 2000 and June 30, 2000. Copies of these filings are available from Renal
Care Group upon request.
-END-
RENAL CARE GROUP, INC.
2100 WEST END AVENUE, SUITE 800
NASHVILLE, TENNESSEE 37203
(615) 345-5500 - (615) 345-5505 FACSIMILE
